Annual report pursuant to Section 13 and 15(d)

Fair Value of Financial Instruments (Tables)

v3.22.1
Fair Value of Financial Instruments (Tables)
12 Months Ended
Dec. 31, 2021
Fair Value Disclosures [Abstract]  
Schedule of liabilities at fair value on a recurring basis
The following tables present information about the Company’s liabilities that are measured at fair value on a recurring basis as of December 31, 2021 and 2020, as well as indicate the fair value hierarchy level of the valuation techniques and inputs that the Company utilized to determine such fair value:
December 31, 2021 Quoted Prices in Active Markets Significant Other Observable Input Significant Other Unobservable Inputs
(Level 1) (Level 2) (Level 3)
(in thousands)
Liabilities
Public Warrants 8,697  —  — 
Private Placement Warrants —  —  3,496 
Sponsor Shares —  —  4,732 
$ 8,697  $ —  $ 8,228 
December 31, 2020 Quoted Prices in Active Markets Significant Other Observable Input Significant Other Unobservable Inputs
(Level 1) (Level 2) (Level 3)
(in thousands)
Liabilities
Series B Preferred Stock Warrants $ —  $ —  $ 508 
Series C Preferred Stock Warrants —  —  50 
$ —  $ —  $ 558 
Schedule of change sin the fair value of Level 3 liabilities
The following is a summary of changes in the fair value of the Level 3 liabilities during the year ended December 31, 2021:
Bridge Notes Consent Fee Liability Sponsor Shares Private Placement Warrants Class A Common Stock Warrants Preferred Stock Warrant Series B and C
(in thousands)
Balance, January 1, 2021 $ —  $ —  $ —  $ —  $ —  $ 558 
Issuance of financial instruments carried at fair value —  —  —  —  18,800 
Liability recorded at fair value 77,033  2,715  17,659  14,902  —  — 
Loss (gain) from changes in fair value 64  (251) (12,927) (11,406) 19,529  1,568 
Settlement(1)
(77,097) (2,464) —  —  (38,329) (2,126)
Balance, December 31, 2021 $ —  $ —  $ 4,732  $ 3,496  $ —  $ — 
1.Bridge Notes were converted to class A common stock, Consent fees were settled for cash and all warrants were exercised.